TASI 8040 · Insurance · MUTAKAMELA
Statement of Changes in Equity
9M / Q3 2023Equity movements
| Movement | Total equity · SARSAR |
|---|---|
| Balance at 1 January 2023 (audited) | 699,876,930 |
| Transition adjustment on initial application of IFRS 17Note 3.2.4 | 14,086,032 |
| Transition adjustment on initial application of IFRS 9Note 3.3.4 | 38,984,828 |
| Deferred taxNote 3.3.4 | (4,203,672) |
| Balance at 1 January 2023 (restated) | 748,744,118 |
| Net income / (loss) attributable to shareholders after zakat and income tax | 23,595,661 |
| Changes in fair value of FVOCI investments | (3,403,249) |
| Deferred tax relating to change in fair value | 439,040 |
| Other reserves | (634,363) |
| Total comprehensive income / (loss) for the period | 19,997,089 |
| Purchase of treasury shares under employee scheme | (2,916,946) |
| Balance at 30 September 2023 | 765,824,261 |
| Balance at 1 January 2022 (audited) | 711,293,024 |
| Transition adjustment on initial application of IFRS 17Note 3.2.4 | 13,529,562 |
| Transition adjustment on initial application of IFRS 9Note 3.3.4 | 34,736,214 |
| Deferred taxNote 3.3.4 | (3,727,925) |
| Balance at 1 January 2022 (restated) | 755,830,875 |
| Net income / (loss) attributable to shareholders after zakat and income tax | (1,816,570) |
| Changes in fair value of FVOCI investments | (38,789,019) |
| Deferred tax relating to change in fair value | 4,844,749 |
| Other reserves | 1,719,836 |
| Total comprehensive income / (loss) for the period | (34,041,004) |
| Balance at 30 September 2022 (restated) | 721,789,871 |